Use of adenosine receptor agonists in therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7076 (2006.01) A61P 21/02 (2006.01) A61P 25/08 (2006.01) A61P 25/28 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2514848

Use of compounds of formula: (I) wherein R is C1-4 alkoxy and X is H or OH; for the prevention, treatment, or amelioration of cancer, inflammation, auto- immune disease, ischemia-reperfusion injury, epilepsy, sepsis, septic shock, neurodegeneration (including Alzheimer's Disease), muscle fatigue or muscle cramp is described. The compounds are effective at very low doses, and so can be administered at doses at which serious side effects are not observed.

La présente invention a trait à des composés de formule (I), dans laquelle R est alcoxy en C¿1?-C¿4? et X est H ou OH, pour la prévention, le traitement, ou l'amélioration du cancer, de l'inflammation, de maladie auto-immune, de la lésion de retour de la perfusion ischémique, de l'épilepsie, de la sepsie, du choc septique, de la neurodégénérescence (y compris la maladie d'Alzheimer), de la fatigue musculaire ou de crampe musculaire. Les composés sont efficaces en très petites doses, et peuvent être administrés en des doses pour lesquelles il n'y a pas d'effets secondaires notables.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of adenosine receptor agonists in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of adenosine receptor agonists in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine receptor agonists in therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1503415

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.